Home ETF List About

Portfolio Holdings Detail for ISIN IE0003WV2ME7
Stock Name / FundiShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF TickerISPE(GBP) LSE
ETF TickerISPE.L(GBP) LSE

Holdings detail for CRL

Stock NameCreightons Plc
TickerCRL(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB0002341666
LEI213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen
Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO
(RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy
Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price
In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades
Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications
The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)
Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)
Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc) CRL holdings

DateNumber of CRL Shares HeldBase Market Value of CRL SharesLocal Market Value of CRL SharesChange in CRL Shares HeldChange in CRL Base ValueCurrent Price per CRL Share HeldPrevious Price per CRL Share Held
2025-09-18 (Thursday)57,685CRL holding increased by 68USD 9,055,968CRL holding increased by 256700USD 9,055,96868USD 256,700 USD 156.99 USD 152.72
2025-09-17 (Wednesday)57,617USD 8,799,268CRL holding increased by 64531USD 8,799,2680USD 64,531 USD 152.72 USD 151.6
2025-09-16 (Tuesday)57,617USD 8,734,737CRL holding decreased by -36875USD 8,734,7370USD -36,875 USD 151.6 USD 152.24
2025-09-15 (Monday)57,617USD 8,771,612USD 8,771,612
2025-09-12 (Friday)57,617USD 8,809,063USD 8,809,063
2025-09-10 (Wednesday)57,617USD 8,830,958USD 8,830,958
2025-09-09 (Tuesday)57,651USD 9,073,114USD 9,073,114
2025-09-08 (Monday)57,651USD 9,339,462USD 9,339,462
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE0003WV2ME7

Show aggregate share trades of CRL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY68 156.990* 161.16
2025-08-18BUY62 156.980* 161.28
2025-08-12SELL-34 152.750* 161.41 Profit of 5,488 on sale
2025-07-29BUY36 178.450* 161.19
2025-07-23SELL-102 167.950* 160.98 Profit of 16,419 on sale
2025-07-22SELL-204 163.360* 160.96 Profit of 32,836 on sale
2025-07-21SELL-68 149.790* 161.02 Profit of 10,950 on sale
2025-07-18SELL-170 154.480* 161.06 Profit of 27,380 on sale
2025-07-15SELL-68 154.420* 161.16 Profit of 10,959 on sale
2025-07-14SELL-170 158.040* 161.17 Profit of 27,399 on sale
2025-07-11SELL-102 159.400* 161.18 Profit of 16,441 on sale
2025-07-10SELL-408 163.660* 161.17 Profit of 65,757 on sale
2025-07-09SELL-136 158.970* 161.18 Profit of 21,921 on sale
2025-07-08SELL-442 158.390* 161.20 Profit of 71,250 on sale
2025-07-03SELL-578 157.120* 161.29 Profit of 93,225 on sale
2025-07-02SELL-105 157.490* 161.31 Profit of 16,938 on sale
2025-06-27SELL-1,666 150.010* 161.44 Profit of 268,953 on sale
2025-06-25BUY34 150.210* 161.56
2025-06-24SELL-1,258 148.400* 161.64 Profit of 203,349 on sale
2025-06-23SELL-34 147.380* 161.73 Profit of 5,499 on sale
2025-06-20BUY10,566 147.450* 161.82
2025-06-18SELL-168 145.290* 162.03 Profit of 27,221 on sale
2025-06-17SELL-308 145.050* 162.13 Profit of 49,937 on sale
2025-06-11SELL-84 151.110* 162.27 Profit of 13,631 on sale
2025-06-10SELL-196 151.000* 162.34 Profit of 31,819 on sale
2025-06-06SELL-56 144.700* 162.55 Profit of 9,103 on sale
2025-06-05SELL-476 141.200* 162.69 Profit of 77,441 on sale
2025-06-02SELL-2,268 135.040* 163.17 Profit of 370,064 on sale
2025-05-30SELL-504 135.630* 163.35 Profit of 82,330 on sale
2025-05-29SELL-56 137.700* 163.53 Profit of 9,157 on sale
2025-05-27SELL-56 138.650* 163.88 Profit of 9,177 on sale
2025-05-23SELL-84 136.730* 164.26 Profit of 13,798 on sale
2025-05-16SELL-420 140.970* 165.16 Profit of 69,366 on sale
2025-05-15SELL-84 138.890* 165.35 Profit of 13,889 on sale
2025-05-13SELL-28 144.020* 165.70 Profit of 4,640 on sale
2025-05-12SELL-196 143.080* 165.87 Profit of 32,510 on sale
2025-05-09SELL-168 138.790* 166.07 Profit of 27,900 on sale
2025-05-08SELL-812 141.360* 166.25 Profit of 134,999 on sale
2025-05-07SELL-56 136.970* 166.48 Profit of 9,323 on sale
2025-05-06BUY24 115.410* 166.87
2025-05-01BUY1,064 116.890* 168.01
2025-04-30BUY588 118.620* 168.39
2025-04-29SELL-112 117.290* 168.80 Profit of 18,906 on sale
2025-04-28SELL-140 115.080* 169.23 Profit of 23,692 on sale
2025-04-25BUY56 114.660* 169.67
2025-04-24SELL-28 115.760* 170.11 Profit of 4,763 on sale
2025-04-22SELL-3,752 106.890* 171.14 Profit of 642,101 on sale
2025-04-17SELL-1,708 106.050* 172.82 Profit of 295,175 on sale
2025-04-16BUY56 104.250* 173.41
2025-04-15BUY56 105.920* 173.99
2025-04-11SELL-1,764 99.750* 175.23 Profit of 309,104 on sale
2025-04-09BUY140 139.070* 176.22
2025-04-08BUY28 123.610* 176.70
2025-04-07BUY504 134.070* 177.09
2025-04-04BUY308 136.900* 177.45
2025-04-02BUY196 149.280* 177.72
2025-04-01BUY2,212 145.990* 178.01
2025-03-31BUY84 150.520* 178.27
2025-03-25BUY28 161.350* 179.05
2025-03-21BUY3,511 167.280* 179.29
2025-03-20BUY54 165.350* 179.43
2025-03-18BUY135 176.940* 179.52
2025-03-17BUY17 175.010* 179.56
2025-03-14SELL-10 171.040* 179.65 Profit of 1,797 on sale
2025-03-13SELL-1,750 166.930* 179.79 Profit of 314,630 on sale
2025-03-12BUY324 170.590* 179.89
2025-03-11BUY324 166.630* 180.03
2025-03-07BUY108 175.920* 180.13
2025-03-06BUY378 169.270* 180.25
2025-03-05BUY2,052 167.550* 180.40
2025-03-04BUY108 164.310* 180.58
2025-03-03BUY135 163.500* 180.78
2025-02-28BUY270 165.310* 180.96
2025-02-27BUY243 164.880* 181.16
2025-02-26SELL-140 167.960* 181.31 Profit of 25,384 on sale
2025-02-25SELL-27 167.100* 181.49 Profit of 4,900 on sale
2025-02-24BUY27 170.510* 181.62
2025-02-20SELL-351 162.250* 182.10 Profit of 63,918 on sale
2025-02-19BUY108 165.000* 182.32
2025-02-18BUY110 154.390* 182.69
2025-02-13BUY3,078 153.170* 183.91
2025-02-12BUY918 154.000* 184.32
2025-02-11BUY756 154.900* 184.73
2025-02-07BUY81 163.790* 185.39
2025-02-06BUY1,080 166.270* 185.66
2025-02-05BUY540 165.870* 185.96
2025-02-04BUY405 163.120* 186.30
2025-02-03SELL-2,349 161.620* 186.67 Profit of 438,487 on sale
2025-01-31BUY216 164.760* 187.01
2025-01-30BUY27 165.570* 187.34
2025-01-29BUY459 161.640* 187.75
2025-01-28BUY162 163.640* 188.14
2025-01-27BUY162 165.840* 188.50
2025-01-24BUY162 164.970* 188.90
2025-01-23BUY459 166.860* 189.27
2025-01-22BUY270 168.220* 189.63
2025-01-21BUY1,593 169.810* 189.98
2025-01-17BUY324 163.500* 190.94
2025-01-15BUY162 173.910* 191.74
2025-01-13BUY459 190.140* 192.04
2025-01-10BUY352 186.120* 192.16
2024-12-31BUY81 184.600* 192.71
2024-12-30BUY108 183.420* 192.92
2024-12-27BUY527 186.160* 193.07
2024-12-23BUY162 185.390* 193.58
2024-12-20BUY3,432 185.770* 193.78
2024-12-19BUY300 182.150* 194.08
2024-12-17BUY229 189.330* 194.50
2024-12-16BUY75 190.070* 194.62
2024-12-13BUY125 190.460* 194.74
2024-12-11BUY75 193.550* 194.78
2024-12-10BUY50 197.050* 194.71
2024-12-09BUY50 201.750* 194.49
2024-12-05SELL-150 191.540* 194.67 Profit of 29,201 on sale
2024-12-04BUY26 199.350* 194.51
2024-12-02BUY100 201.250* 194.09
2024-11-29BUY450 199.060* 193.89
2024-11-27BUY100 199.590* 193.42
2024-11-26BUY250 197.750* 193.23
2024-11-25BUY3,100 201.300* 192.87
2024-11-22BUY75 195.770* 192.73
2024-11-21BUY75 194.190* 192.65
2024-11-20BUY325 187.900* 192.90
2024-11-19SELL-325 186.100* 193.28 Profit of 62,817 on sale
2024-11-18BUY1,500 187.500* 193.62
2024-11-12BUY300 215.940* 192.23
2024-11-11BUY75 220.690* 190.33
2024-11-08BUY301 215.390* 188.54
2024-11-07BUY506 210.290* 186.87
2024-11-06BUY225 214.200* 184.59
2024-11-05BUY50 188.680* 184.22
2024-11-04BUY255 182.480* 184.39
2024-11-01BUY125 180.960* 184.77
2024-10-30BUY75 181.390* 186.14
2024-10-29BUY475 184.000* 186.50
2024-10-25BUY100 182.120* 187.58
2024-10-24BUY75 182.730* 189.20
2024-10-22BUY150 185.940* 195.04
2024-10-21BUY125 195.040* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1998,1391131,07574.9%
2025-09-1862,9972121,43651.9%
2025-09-1792,1290727,00512.7%
2025-09-16115,39612317,67336.3%
2025-09-1566,3561151,09343.9%
2025-09-1277,5570176,81743.9%
2025-09-1187,9991204,23743.1%
2025-09-10122,6560398,56430.8%
2025-09-09125,4020471,64226.6%
2025-09-08178,3420414,72943.0%
2025-09-0576,2640192,66839.6%
2025-09-0494,7920179,53352.8%
2025-09-03139,6460216,26564.6%
2025-09-02112,81930183,91061.3%
2025-08-29105,9651,040180,20658.8%
2025-08-28183,9714248,97873.9%
2025-08-2771,8910134,03453.6%
2025-08-26109,85319166,15266.1%
2025-08-25147,16623300,78148.9%
2025-08-22251,1260414,08560.6%
2025-08-21102,1520149,37668.4%
2025-08-20152,7210215,94670.7%
2025-08-19118,8310172,88768.7%
2025-08-1893,0280164,64156.5%
2025-08-1596,5001180,16553.6%
2025-08-14147,9520251,45658.8%
2025-08-13820,20601,075,15376.3%
2025-08-12299,3220438,69968.2%
2025-08-11192,9170365,05852.8%
2025-08-0892,08966222,12841.5%
2025-08-07326,647522550,23059.4%
2025-08-06532,4347,827888,87359.9%
2025-08-05283,1486539,93852.4%
2025-08-04124,11154248,83449.9%
2025-08-01162,441300281,62257.7%
2025-07-31125,6480228,70654.9%
2025-07-30115,4870188,12161.4%
2025-07-29181,1590275,84365.7%
2025-07-28198,89649321,94161.8%
2025-07-25162,642111293,83155.4%
2025-07-24385,658456820,47247.0%
2025-07-23150,6500346,02043.5%
2025-07-22205,73626821,85325.0%
2025-07-21132,794101445,92029.8%
2025-07-1893,150207186,54249.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.